| Investigating the Clinical Consequences of Flutemetamol-PET-scanning (NCT02353949) | University of Zurich | 2015-05-01 |
| Rasagiline Rescue in Alzheimer's Disease Clinical Trial (NCT02359552) | The Cleveland Clinic | 2015-05-01 |
| Translation of COPE for Publicly-Funded Home Care Clients and Their Families (NCT02365051) | UConn Health | 2015-05-01 |
| Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease (NCT02501876) | Hospital Universitari Vall d'Hebron Research Institute | 2015-05-01 |
| aeRobic Exercise and Cognitive Health (NCT02384993) | University of Wisconsin, Madison | 2015-04-28 |
| Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD (NCT02423200) | EIP Pharma Inc | 2015-04-01 |
| A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD) (NCT02423122) | EIP Pharma Inc | 2015-04-01 |
| Health Evaluation in African Americans Using RAS Therapy (NCT02471833) | Emory University | 2015-04-01 |
| Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease (NCT02080364) | vTv Therapeutics | 2015-04-01 |
| Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart (NCT02462161) | Wake Forest University Health Sciences | 2015-03-20 |
| A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. (NCT02377713) | Kyowa Kirin Co., Ltd. | 2015-03-01 |
| Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia (NCT02397980) | Ewha Womans University Mokdong Hospital | 2015-03-01 |
| Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease (NCT02389413) | Vivoryon Therapeutics N.V. | 2015-03-01 |
| Retinoic Acid Homeostasis in Neuropsychiatric Diseases (NCT02439099) | Charite University, Berlin, Germany | 2015-03-01 |
| Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE) (NCT02403752) | University of California, San Francisco | 2015-03-01 |
| Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose) (NCT02534480) | NeuroGenetic Pharmaceuticals Inc | 2015-03-01 |
| A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients (NCT02158910) | Eisai Korea Inc. | 2015-03-01 |
| Tau Imaging in Professional Fighters (NCT02278354) | Avid Radiopharmaceuticals | 2015-02-18 |
| Benfotiamine in Alzheimer's Disease: A Pilot Study (NCT02292238) | Burke Medical Research Institute | 2015-02-15 |
| Aggression Prevention Training for Caregivers of Persons With Dementia (APT) (NCT02380703) | Baylor College of Medicine | 2015-02-05 |
| Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms (NCT02626572) | Institut de Recherches Internationales Servier | 2015-02-01 |
| Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease (NCT02386306) | GliaCure, Inc. | 2015-02-01 |
| Augmenting Flortaucipir Dosimetry Estimates (NCT02336360) | Avid Radiopharmaceuticals | 2015-01-01 |
| Reminiscence, Anxiety and Early Alzheimer's Disease (NCT02319681) | Emory University | 2015-01-01 |
| Clinical Evaluation of Flortaucipir F 18 (NCT02278367) | Avid Radiopharmaceuticals | 2014-12-01 |
| A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease (NCT02167256) | Yale University | 2014-12-01 |
| ATP in Alzheimer Disease (NCT02279511) | Sara Varea | 2014-12-01 |
| Safety Study of MT-4666 in Subjects With Alzheimer's Disease (NCT02327182) | Tanabe Pharma Corporation | 2014-12-01 |
| Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment (NCT02155946) | VA Office of Research and Development | 2014-12-01 |
| Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg (NCT02550665) | Asan Medical Center | 2014-12-01 |
| A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease (NCT02260674) | Janssen Research & Development, LLC | 2014-11-01 |
| Effects of a NeuroAD System, for the Treatment of Alzheimer Disease (NCT02166827) | Neuronix Ltd | 2014-11-01 |
| Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads (NCT02506374) | Yale University | 2014-11-01 |
| Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program (NCT02300584) | Emory University | 2014-11-01 |
| Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (NCT02002819) | University of Minnesota | 2014-10-16 |
| Personalized Music Therapy and Agitation in Dementia (NCT02147652) | University Health Network, Toronto | 2014-10-14 |
| Mass Practice of Activities of Daily Living in Dementia (STOMP) (NCT02356055) | University of Oklahoma | 2014-10-01 |
| Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians (NCT02029547) | Avid Radiopharmaceuticals | 2014-10-01 |
| An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease (NCT02245737) | AstraZeneca | 2014-09-30 |
| Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol (NCT02260167) | Practitioners Alliance Network | 2014-09-01 |
| Alzheimer's Caregiver Coping: Mental and Physical Health (NCT02317523) | University of California, San Diego | 2014-09-01 |
| Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease (NCT02360527) | Hospital Universitari Vall d'Hebron Research Institute | 2014-09-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors (NCT02220738) | AbbVie | 2014-09-01 |
| Cognitive Rehabilitation in Alzheimer's Disease (NCT02247180) | University of Rostock | 2014-09-01 |
| The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study (NCT02256306) | Stanford University | 2014-09-01 |
| A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease (NCT02227953) | Samsung Medical Center | 2014-08-01 |
| Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease (NCT02330510) | Dr. Sandra E Black | 2014-08-01 |
| A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects (NCT02061878) | ReXceptor, Inc. | 2014-08-01 |
| Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease (NCT02176629) | Centre Hospitalier Universitaire de Nice | 2014-08-01 |
| 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients (NCT01948791) | Novartis Pharmaceuticals | 2014-08-01 |
| Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) (NCT02245568) | TauRx Therapeutics Ltd | 2014-08-01 |
| A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia (NCT02185053) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2014-07-31 |
| S-Equol in Alzheimer's Disease (SEAD) Trial (NCT02142777) | Russell Swerdlow, MD | 2014-07-01 |
| A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease (NCT02127476) | Kyowa Kirin Co., Ltd. | 2014-07-01 |
| A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) (NCT02262975) | Eisai Korea Inc. | 2014-07-01 |
| Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia (NCT02210286) | Stanford University | 2014-07-01 |
| Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic (NCT02654574) | Hospices Civils de Lyon | 2014-06-01 |
| Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease (NCT02221947) | Neurotrope Bioscience, Inc. | 2014-06-01 |
| Treatment of Psychosis and Agitation in Alzheimer's Disease (NCT02129348) | New York State Psychiatric Institute | 2014-06-01 |
| Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 (NCT02004392) | FORUM Pharmaceuticals Inc | 2014-06-01 |
| n-3 PUFA for Vascular Cognitive Aging (NCT01953705) | Oregon Health and Science University | 2014-05-01 |
| Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease (NCT02137460) | Seoul National University Hospital | 2014-05-01 |
| Imaging Characteristics of a Follow-up 18F-AV-1451 Scan (NCT02051764) | Avid Radiopharmaceuticals | 2014-05-01 |
| The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease (NCT02253043) | Beijing Pins Medical Co., Ltd | 2014-05-01 |
| Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging (NCT02767609) | Loma Linda University | 2014-05-01 |
| Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) (NCT02064920) | Merck Sharp & Dohme LLC | 2014-04-22 |
| Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease (NCT02079246) | H. Lundbeck A/S | 2014-04-07 |
| Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease (NCT02222181) | Universidade Estadual Paulista Júlio de Mesquita Filho | 2014-04-01 |
| Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old (NCT02198586) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2014-04-01 |
| Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study (NCT02018913) | Maastricht University Medical Center | 2014-04-01 |
| Gray Matters Alzheimer's Disease Prevention Intervention (NCT02290912) | Utah State University | 2014-04-01 |
| Florbetapir Calibration to the Centiloid Scale (NCT02120664) | Avid Radiopharmaceuticals | 2014-04-01 |
| A Study of Gantenerumab in Participants With Mild Alzheimer Disease (NCT02051608) | Hoffmann-La Roche | 2014-03-27 |
| The Feasibility of Florbetapir Quantitation in Europe (NCT02107599) | Avid Radiopharmaceuticals | 2014-03-01 |
| Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor (NCT02006654) | H. Lundbeck A/S | 2014-03-01 |
| Inhalational Anesthesia and Precipitation of Dementia: is There a Link? (NCT01903421) | University Health Network, Toronto | 2014-03-01 |
| Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) (NCT02079909) | FUJIFILM Toyama Chemical Co., Ltd. | 2014-03-01 |
| Porphyromonas Gingivalis and Alzheimer's Disease (NCT02109705) | University Hospital Muenster | 2014-03-01 |
| Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients (NCT02085265) | Sunnybrook Health Sciences Centre | 2014-03-01 |
| Evaluation of Reader Training Processes (NCT02051790) | Avid Radiopharmaceuticals | 2014-03-01 |
| Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease (NCT02054208) | Medipost Co Ltd. | 2014-03-01 |
| Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study (NCT02114372) | Janssen Research & Development, LLC | 2014-02-05 |
| Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles (NCT02063269) | Seoul National University Hospital | 2014-02-01 |
| Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease? (NCT02051244) | Carmel Medical Center | 2014-02-01 |
| Oxaloacetate Pharmacokinetics and Safety (NCT02063308) | Russell Swerdlow, MD | 2014-02-01 |
| Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease (NCT02097056) | Eisai Korea Inc. | 2014-02-01 |
| Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil (NCT02006641) | H. Lundbeck A/S | 2014-02-01 |
| Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia (NCT02078310) | Intra-Cellular Therapies, Inc. | 2014-02-01 |
| The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) (NCT01767909) | University of Southern California | 2014-01-08 |
| Co-LEsions in Alzheimer Disease and Related Disorders (NCT02052947) | Hospices Civils de Lyon | 2014-01-01 |
| Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres (NCT02418806) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2014-01-01 |
| Evaluating Liraglutide in Alzheimer's Disease (NCT01843075) | Imperial College London | 2014-01-01 |
| 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (NCT02031198) | Axon Neuroscience SE | 2014-01-01 |
| Wake Forest Alzheimer's Disease Clinical Core (NCT03140865) | Wake Forest University Health Sciences | 2014-01-01 |
| Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression (NCT02303158) | Institut Investigacio Sanitaria Pere Virgili | 2014-01-01 |
| Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults (NCT02051335) | AstraZeneca | 2014-01-01 |
| AZD3293 Thorough QT Study in Healthy Male Volunteers (NCT02040987) | AstraZeneca | 2014-01-01 |
| A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort (NCT01998841) | Genentech, Inc. | 2013-12-20 |
| Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects (NCT02016560) | Avid Radiopharmaceuticals | 2013-12-01 |
| CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease (NCT02021682) | Washington University School of Medicine | 2013-12-01 |